TY - JOUR AU - Martinot, Martin AU - Ahle, Guido AU - Petrosyan, Inesa AU - Martinez, Camille AU - Gorun, Dragos AU - Mohseni-Zadeh, Mahsa AU - Fafi-Kremer, Samira AU - Tebacher-Alt, Martine T1 - Progressive Multifocal Leukoencephalopathy after Treatment with Nivolumab T2 - Emerging Infectious Disease journal PY - 2018 VL - 24 IS - 8 SP - 1594 SN - 1080-6059 AB - Progressive multifocal leukoencephalopathy (PML) is increasingly being reported in patients undergoing immunotherapy. We report a case of progressive multifocal leukoencephalopathy after treatment with nivolumab, a PD-1 blocker that is used to restore impaired T-cell responses in patients with cancer and infections. Data for 4 other cases were obtained from pharmacovigilance databases. KW - nivolumab KW - immune checkpoint inhibitor KW - progressive multifocal leukoencephalopathy KW - JC virus KW - viruses KW - meningtitis/encephalaitis KW - meningtitis/encephalitis KW - HIV/AIDS and other retroviruses DO - 10.3201/eid2408.180460 UR - https://wwwnc.cdc.gov/eid/article/24/8/18-0460_article ER - End of Reference